Document Detail

Effect of beta blocker therapy on survival of patients with heart failure and preserved systolic function following hospitalization with acute decompensated heart failure.
MedLine Citation:
PMID:  22560389     Owner:  NLM     Status:  In-Data-Review    
BACKGROUND: The importance of heart failure with preserved ejection fraction is being increasingly recognized. However, there is a paucity of data about effective treatment for this condition. The present study investigated the impact of beta blocker therapy for 3months before admission on the two-year survival of patients with heart failure and preserved systolic function hospitalized due to decompensated heart failure.
METHODS: We performed a retrospective cohort analysis of 345 consecutive patients with heart failure with preserved systolic function older than 18years hospitalized due to decompensated heart failure. Two groups of patients were compared: those who received beta blockers within 3months before admission (BB) and those who did not (NBB). The primary outcome was two year all cause mortality (maximal follow-up available in all subjects). To adjust for a potential misbalance between BB and NBB groups in baseline characteristics, a propensity score for beta blocker therapy was incorporated into the survival model.
RESULTS: 154 patients (44.6%) received beta blockers prior to admission. Overall two year mortality rate in the BB group was 50% vs. 62.8% in the NBB group, log-rank test p=0.016. Beta blockers showed protective effect on two-year survival after adjustment for comorbidities and propensity score (hazard ratio [HR], 0.69; 95% CI 0.47-0.99).
CONCLUSIONS: Therapy with beta blockers may have protective effect on survival of patients with heart failure with preserved systolic function.
Roman Nevzorov; Avi Porath; Yaakov Henkin; Sergio L Kobal; Alan Jotkowitz; Victor Novack
Related Documents :
25265869 - Fabp4-creer lineage tracing revealstwo distinctive coronary vascular populations.
22201979 - Beta-adrenoceptor signaling pathways mediate cardiac pathological remodeling.
16333239 - Levosimendan: dual mechanisms for acute heart failure...and beyond?
19516249 - Effects of hemodialysis on cardiac function.
24784009 - Perforator infarction immediately distal to the stenosis of parental artery: is it hemo...
9894619 - Angiotensin-converting enzyme inhibition and vascular remodeling in coronary artery dis...
21950619 - Estimation of left ventricular function using a novel acoustic-based device.
25238499 - Cardiac function after acute support with direct mechanical ventricular actuation in ch...
9193029 - Comparison of right ventricular outflow tract and apical lead permanent pacing on cardi...
Publication Detail:
Type:  Journal Article     Date:  2012-02-27
Journal Detail:
Title:  European journal of internal medicine     Volume:  23     ISSN:  1879-0828     ISO Abbreviation:  Eur. J. Intern. Med.     Publication Date:  2012 Jun 
Date Detail:
Created Date:  2012-05-07     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9003220     Medline TA:  Eur J Intern Med     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  374-8     Citation Subset:  IM    
Copyright Information:
Copyright © 2012. Published by Elsevier B.V.
Department of Cardiology, Rabin Medical Center, Petah Tikva, Tel Aviv University's Sackler Medical School, Israel.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Clinical significance of sCD105 in angiogenesis and disease activity in multiple myeloma.
Next Document:  Residual pulmonary thromboemboli after acute pulmonary embolism.